Sunday, May 5, 2024
Home Client Page 21

Client

    Random
    True Nature, Mitesco, Biotech Stock Review

    True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

    Accelerator Editor / Curator -
    Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
    Hapbee, Biotech Stock Review

    Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

    Telehealth Editor / Curator -
    My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
    Dalrada

    Dalrada (DFCO) Finally Pops. Up 59% Today.

    Client Editor / Curator -
    Up 59% today on news and with 4 million shares trading and counting! LIVE QUOTE

    Citius Pharma (CTXR) Video Presentation.

    Interview Editor / Curator -
    Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment...

    Adding Geovax (GOVX) to 2024 Biotech Watch List.

    Client Editor / Curator -
    GEOVAX (GOVX) $0.32 We added this to the Watch List earlier in the...

    Circle Group Holdings (CRGQ) $0.47 Report.

    Research Editor / Curator -
    Click to Download. Client, we were compensated with 100,000 shares and warrants to purchase...
    Biotech Stock Review

    Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

    2021 Watch List Editor / Curator -
    Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...
    Draganfly, Drone Stock Review

    Draganfly (DPRO) Closes $20 Million Public Offering. Now NASDAQ Listed.

    Drones Editor / Curator -
    Los Angeles, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a...

    Smart For Life (SMFL) $0.37 Announces Initiation of Equity Analyst Coverage by Dawson James...

    All News Editor / Curator -
    Initiates with “Buy” recommendation and $8 price target. MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life,...
    ehave,

    Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.

    Telehealth Editor / Curator -
    Contactless Health Screening Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...
    1...202122...36Page 21 of 36

    Latest article

    We’re in Tampa for the Kentucky Derby.

    Client Editor / Curator -
    GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

    Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

    Institutional Analyst Newsletter Editor / Curator -
    DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

    Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

    Client Editor / Curator -
    Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.